![Kannan Kashi Vishwanath](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kannan Kashi Vishwanath
Corporate Officer/Principal en Indo-American Chamber of Commerce & Industry .
Cargos activos de Kannan Kashi Vishwanath
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Indo-American Chamber of Commerce & Industry | Corporate Officer/Principal | 17/06/2011 | - |
Historial de carrera de Kannan Kashi Vishwanath
Antiguos cargos conocidos de Kannan Kashi Vishwanath.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
FINAVENTURE CAPITAL LTD | Director/Miembro de la Junta | - | 14/02/2015 |
Director Ejecutivo | 01/07/2010 | 14/02/2015 | |
DR DATSONS LABS LTD | Director/Miembro de la Junta | 17/06/2011 | 21/08/2014 |
Director Ejecutivo | 17/06/2011 | 21/08/2014 | |
Fundador | 03/01/2006 | 21/08/2014 |
Formación de Kannan Kashi Vishwanath.
University of Pune | Undergraduate Degree |
Hamilton College (New York) | Masters Business Admin |
The International University | Doctorate Degree |
Estadísticas
Internacional
India | 5 |
Estados Unidos | 2 |
Austria | 2 |
Operativa
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Founder | 1 |
Sectorial
Consumer Services | 4 |
Finance | 2 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Finaventure Capital Ltd.
![]() Finaventure Capital Ltd. Investment ManagersFinance Finaventure Capital Ltd. is an investment company, which engages in the business of investments in listed and unlisted companies. The company was founded on January 19, 1985 and is headquartered in Mumbai, India. | Finance |
Dr.Datsons Labs Ltd.
![]() Dr.Datsons Labs Ltd. Pharmaceuticals: MajorHealth Technology Dr. Datsons Labs Ltd. engages in the manufacture, and market of contract research and manufacturing services (CRAMS), and active pharmaceutical ingredients (API). It operates through the following segments: Active Pharmaceutical Ingredients (API), Formulation, and Trading. The API segment manufactures second generation anti-malaria APIs like quinine and salts as well as third generation anti-malarial products like Artemisinin-based salts. The company was founded by Kannan Kashi Vishwanathan on January 3, 2006 and is headquartered in Mumbai, India. | Health Technology |
Indo-American Chamber of Commerce & Industry |